aileronrx.com - RNTX Profit before deduction of interest, taxes, depreciation and amortization

Public company logo of Rein Therapeutics (RNTX)

The independence of biotech development from economic cycles ensures a stable level of investor confidence, which confirms the significance of Rein Therapeutics Inc (RNTX) EBITDA. The current 0.00 metric defines this level on the chart, reflecting financial stability. The picture is completed by streamlined molecule transportation logistics, guaranteeing the continuity of clinical trials in the rare disease segment.

aileronrx.com (RNTX) Operating profit EBITDA: for the period 11/23/2025 - 11/15/2026

Summary analytical data breakdowns for Rein Therapeutics (RNTX)

- stock value and consensus price forecast:
Summary company analytics:Rein Therapeutics Inc
Brand item of aileronrx.com

This indicator reflects net cash flow from operating activities, excluding the impact of depreciation and taxes to assess real operational efficiency. For Rein Therapeutics Inc (RNTX), the recorded EBITDA level correlates directly with the success of clinical trials and patent protection of drugs, allowing investors to differentiate the company's fundamental solvency from temporary market fluctuations and evaluate capital stability.

Who Rein Therapeutics Inc competes with

Operating income before deduction of amortization Vertex (VRTX)|ALNY: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization INSM|UTHR: Operating profit EBITDA|Profit before interest, taxes and amortization BioMarin Pharma (BMRN)|BBIO (BridgeBio) - Operating profit EBITDA|BGM: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization COGT (Cogent Biosciences, Inc.)|XERS (Xeris Biopharma Holdings, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Keros Therapeutics, Inc. KROS|ARCT (Arcturus Pharma) - Profit before deduction of interest, taxes, depreciation and amortization|Eton Pharmaceuticals - Operating profit EBITDA|Income before deduction of interest, taxes and amortization KMDA (Kamada Ltd.)|FULC: Operating profit EBITDA|Abeona (ABEO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization mereobiopharma.com|Operating profit before deduction of amortization Protalix (PLX)|Profit before payment of interest, taxes and amortization Pliant Therapeutics Inc (PLRX)|Operating profit before deduction of amortization Applied Therapeutics, Inc. APLT|Operating profit EBITDA GELS (Gelteq Ltd)|Operating profit EBITDA Aytu Therapeutics AYTU|Chemomab Therapeutics Ltd. - Operating profit EBITDA|Operating income before deduction of amortization SRx Health Solutions SRXH|polyrizon-biotech.com (PLRZ) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Aeterna Zentaris (AEZS)|CYTH (Cyclo Therapeutics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Inozyme Pharma INZY|Operating profit EBITDA RPHM|Operating profit before deduction of amortization Aeterna Zentaris CSCI